Advertisement
U.S. Markets closed

Sandoz Group AG (SDZ.SW)

Swiss - Swiss Delayed Price. Currency in CHF
37.93-0.54 (-1.40%)
At close: 05:30PM CEST
Full screen
Previous Close38.47
Open38.40
Bid0.00 x N/A
Ask0.00 x N/A
Day's Range37.27 - 38.60
52 Week Range23.42 - 38.60
Volume885,514
Avg. Volume886,671
Market Cap16.307B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.02
Earnings DateAug 08, 2024
Forward Dividend & Yield0.45 (1.17%)
Ex-Dividend DateMay 03, 2024
1y Target Est37.09
  • GlobeNewswire

    Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio

    MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for metastatic breast cancerLaunch expected to be near-term growth driver in US market Princeton, NJ, October 11, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that it has launched a generic paclitaxel formulation in the US, the first generic to its reference medicine to be approved by the US Food and Drug Admi

  • The Wall Street Journal

    Health Care Roundup: Market Talk

    Read about Bausch + Lomb, Sandoz Group and more in the latest Market Talks covering the Health Care sector.